MacroGenics
MGNX
#9383
Rank
NZ$0.15 B
Marketcap
NZ$2.41
Share price
0.72%
Change (1 day)
-58.14%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.15 Billion

As of December 2025 MacroGenics has a market cap of NZ$0.15 Billion. This makes MacroGenics the world's 9383th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.15 B-57.59%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of MacroGenics was reported to be:

NZ$0.15 Billion
by Nasdaq info icon info icon
NZ$0.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$2.10 B 1,283.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$252.28 B 165,408.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$419.68 B 275,225.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$259.14 B 169,904.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$292.30 B 191,659.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.533 T 1,005,699.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$179.43 B 117,615.25%๐Ÿ‡บ๐Ÿ‡ธ USA